These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
212 related items for PubMed ID: 22585765
1. A double-blind, placebo-controlled trial of ω-3 fatty acids in Tourette's disorder. Gabbay V, Babb JS, Klein RG, Panzer AM, Katz Y, Alonso CM, Petkova E, Wang J, Coffey BJ. Pediatrics; 2012 Jun; 129(6):e1493-500. PubMed ID: 22585765 [Abstract] [Full Text] [Related]
2. Effectiveness and tolerability of aripiprazole in children and adolescents with Tourette's disorder: a pilot study in China. Cui YH, Zheng Y, Yang YP, Liu J, Li J. J Child Adolesc Psychopharmacol; 2010 Aug; 20(4):291-8. PubMed ID: 20807067 [Abstract] [Full Text] [Related]
3. Randomized, Double-Blind, Placebo-Controlled Trial Demonstrates the Efficacy and Safety of Oral Aripiprazole for the Treatment of Tourette's Disorder in Children and Adolescents. Sallee F, Kohegyi E, Zhao J, McQuade R, Cox K, Sanchez R, van Beek A, Nyilas M, Carson W, Kurlan R. J Child Adolesc Psychopharmacol; 2017 Nov; 27(9):771-781. PubMed ID: 28686474 [Abstract] [Full Text] [Related]
8. Ondansetron treatment in Tourette's disorder: a 3-week, randomized, double-blind, placebo-controlled study. Toren P, Weizman A, Ratner S, Cohen D, Laor N. J Clin Psychiatry; 2005 Apr; 66(4):499-503. PubMed ID: 15816793 [Abstract] [Full Text] [Related]
9. Effects of Yi-Gan-san on the psychiatric behavior of children and adolescents with Tourette's Syndrome: A randomized, double-blind, controlled preliminary study. Huang CH, Liao WL, Lee DY, Chou IC, Wang MY, Hsieh CL. J Ethnopharmacol; 2022 May 23; 290():115098. PubMed ID: 35182665 [Abstract] [Full Text] [Related]
13. Tourette's syndrome improvement with pergolide in a randomized, double-blind, crossover trial. Gilbert DL, Sethuraman G, Sine L, Peters S, Sallee FR. Neurology; 2000 Mar 28; 54(6):1310-5. PubMed ID: 10746603 [Abstract] [Full Text] [Related]
14. Safety and Efficacy of Flexible-Dose Deutetrabenazine in Children and Adolescents With Tourette Syndrome: A Randomized Clinical Trial. Jankovic J, Coffey B, Claassen DO, Jimenez-Shahed J, Gertz BJ, Garofalo EA, Stamler DA, Wieman M, Savola JM, Gordon MF, Alexander J, Barkay H, Harary E. JAMA Netw Open; 2021 Oct 01; 4(10):e2128204. PubMed ID: 34609495 [Abstract] [Full Text] [Related]
19. Testing tic suppression: comparing the effects of dexmethylphenidate to no medication in children and adolescents with attention-deficit/hyperactivity disorder and Tourette's disorder. Lyon GJ, Samar SM, Conelea C, Trujillo MR, Lipinski CM, Bauer CC, Brandt BC, Kemp JJ, Lawrence ZE, Howard J, Castellanos FX, Woods D, Coffey BJ. J Child Adolesc Psychopharmacol; 2010 Aug 01; 20(4):283-9. PubMed ID: 20807066 [Abstract] [Full Text] [Related]
20. Yale Global Tic Severity Scale (YGTSS): Psychometric Quality of the Gold Standard for Tic Assessment Based on the Large-Scale EMTICS Study. Haas M, Jakubovski E, Fremer C, Dietrich A, Hoekstra PJ, Jäger B, Müller-Vahl KR, EMTICS Collaborative Group. Front Psychiatry; 2021 Aug 01; 12():626459. PubMed ID: 33716826 [Abstract] [Full Text] [Related] Page: [Next] [New Search]